49.41.Z - Road freight transport
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.73.Z - Retail sale of pharmaceutical products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
68.20.Z - Rental and management of own or leased real estate
45.11.Z
45.19.Z
45.40.Z
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,8 | 0,7 | 0,3 | -64,3 |
EBITDA | 0,9 | 1 | 0,5 | -53,6 |
Short time liabilities | 1,7 | 1,5 | 1,7 | 11,4 |
Equity capital | 5 | 5,4 | 5,6 | 3,9 |
Operating profit (EBIT) | 0,8 | 0,9 | 0,3 | -65,9 |
Assets | 6,8 | 7 | 10,2 | 45,7 |
Net profit (loss) | 0,7 | 0,6 | 0,2 | -66,8 |
Cash | 3 | 3,6 | 0,3 | -91,5 |
Net income from sale | 7,6 | 7,2 | 7 | -2,7 |
Liabilities and provisions for liabilities | 1,7 | 1,6 | 4,5 | 192 |
Working assets | 5,3 | 5,3 | 8,7 | 62,5 |
Depreciation | 0,2 | 0,2 | 0,2 | 9,3 |
% | % | % | p.p. | |
Profitability of capital | 13,2 | 11,8 | 3,8 | -8 |
Equity capital to total assets | 74,5 | 77,8 | 55,5 | -22,3 |
Gross profit margin | 9,8 | 10,2 | 3,7 | -6,5 |
EBITDA Margin | 12,1 | 14,2 | 6,8 | -7,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 81 | 77 | 88 | 11 |
Current financial liquidity indicator | 3.04132080078125 | 3.433821201324463 | 1.9107444286346436 | -1,5 |
Net dept to EBITDA | -3.0027787685394287 | -3.402398109436035 | -0.5762913227081299 | 2,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane